Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.

Author: Blom, Dirk J. MBChB, MMed, PhD; Averna, Maurizio R. MD; Meagher, Emma A. MD; du Toit Theron, Hendrik MD; Sirtori, Cesare R. MD, PhD; Hegele, Robert A. MD; Shah, Prediman K. MD; Gaudet, Daniel MD, PhD; Stefanutti, Claudia MD, PhD; Vigna, Giovanni B. MD, PhD; Larrey, Dominique MD, PhD; Bloedon, LeAnne T. BS, MS, RD; Foulds, Pamela MD; Rader, Daniel J. MD; Cuchel, Marina MD, PhD

Page: 332-335

http://ift.tt/2u3C6do